Notice2023-04968
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 10, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 47 (Friday, March 10, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 47 (Friday, March 10, 2023)]
[Notices]
[Pages 15030-15031]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-04968]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-22ET]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ''Traveler-based Genomic Surveillance'' to
the Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on May 6, 2022, to obtain comments
from the public and affected agencies. CDC received one comment related
to the previous notice. This notice serves to allow an additional 30
days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Traveler-based Genomic Surveillance--New--National Center for
[[Page 15031]]
Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention's (CDC), National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division
of Global Migration and Quarantine (DGMQ), Travelers' Health Branch
(THB) requests three-year approval for information collection from
international air travelers that participate in the Traveler-based
Genomic Surveillance project. Genetic variants of SARS-CoV-2 have been
emerging and circulating around the world throughout the COVID-19
pandemic. Of particular concern are variants for which there is
evidence of an increase in transmissibility, more severe disease (for
example, increased hospitalizations or deaths), significant reduction
in neutralization by antibodies generated during previous infection or
vaccination, reduced effectiveness of treatments or vaccines, or
diagnostic detection failures.
CDC recommends that all arriving international travelers get tested
before departing and 3-5 days after travel. However, this testing is
not mandatory for all travelers. Furthermore, there are currently few
systems that conduct disease surveillance in the population of arriving
international travelers. Moreover, as testing and sequencing for SARS-
CoV-2 continue to decline worldwide, detecting emerging variants of
concern (VOCs) in a timely manner is becoming more and more difficult.
To address this gap, in September 2021, the THB, in collaboration
with private partners, implemented a voluntary SARS-CoV-2 genomic
surveillance program with the goal of early detection of novel VOCs.
Surveillance for new and emerging variant strains among travelers can
provide researchers and public health officials critical time to
collect information about the transmissibility, virulence, and
effectiveness of existing vaccines, diagnostics, and therapeutics. The
project is conducted with external partners and groups within DGMQ and
across CDC, including the Office of Advanced Molecular Detection. The
program began at New York's John F. Kennedy International Airport in
September 2021 and later expanded to include Newark Liberty
International, San Francisco International, and Hartsfield-Jackson
Atlanta International airports. Since November 2022, the program has
expanded to Los Angeles, Seattle, and Washington Dulles. Information
collection for this project is currently approved under a Public Health
Emergency PRA Waiver.
The information collection for which approval is sought is in
accordance with CDC/DGMQ's mission to reduce morbidity and mortality
among travelers and to prevent the introduction, transmission, or
spread of communicable diseases from foreign countries into the U.S.
This mission is supported by the Section 361 of the Public Health
Service Act regulations found in 42 Code of Federal Regulations part 70
and 71. Also supported under general authorities provided by Sections
301 and 311 in the Public Health Service Act regulations.
CDC requests OMB approval for an estimated 46,250 annual burden
hours. There is no cost to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Arriving international traveler..... Questionnaire.......... 555,000 1 6/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2023-04968 Filed 3-9-23; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on March 10, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.